Aurora Financial JournalFresenius SE & Co. KGaA (FRE.DE)
Xetra (Frankfurt) · Pharmaceutical industry · Financial statements, TTM figures and earnings dates
In fiscal year 2024 (ended January 1, 2024), Fresenius SE & Co. KGaA reported revenue of €21.53B. Key annual figures are available for fiscal years 2020 to 2024, taken from the key figures recorded on Wikidata.
Open interactive financials →Key financials
| EUR | FY2024 2024-01-01 | FY2023 2023-01-01 | FY2022 2022-01-01 | FY2021 2021-01-01 | FY2020 2020-01-01 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | €21.53B | €22.30B | €40.84B | €37.52B | €36.28B |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in EUR as reported; per-share data adjusted for stock splits.
More on the interactive page
The FRE.DE page on Aurora Financial Journal shows live share prices, valuation multiples and financial data, news and the company profile.
Open FRE.DE →